Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?

doi:10.3748/wjg.v27.i26.4045

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 26

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10160)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-9) series.

Item

Count

PDF

816

WORD

196

HTML

7611

Tables (1-9)

215

Sum=8838

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

483

Download

839

Sum=1322

Jul 14, 2021 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (40)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jul 14, 2021; 27(26): 4045-4087
Published online Jul 14, 2021. doi: 10.3748/wjg.v27.i26.4045

Table 1 Serum protein biomarkers implicated in the diagnosis of pancreatic cancer

Class	Candidate marker
Glycolipids and proteins	CA19-9[27,28,33-38,144,160,182,187,213,221], sTRA[39-41], CEA[43], CA125[47,48,50], CA242[55,53], Osteonectin[57], Osteopontin[58-61], DUPAN-2[65-70], LAMC2[73-75], ULBP2[78-80], sCD40L[82], LRG1[84], C4BPA[86], Cofilin-1[88], sgC1qR[91], Trypsinogen-2[92,93], DKK1[96], THBS-2[99-102], THBS-1[103], AGR2[108], REG1A[108], REGIII[108], REG1β[111], REG4[114-117], SYCN[108], LOXL2[108], PARK7/DJ-1[126], TTR[129,130], TTF1[134], TTF2[134], TTF3[134], GPNMB[138], PRX-1[139], TFPI[141], TIMP-1[144], MMP-9[144], IGFBP-1^[146],IGFBP-2[147-149], IGFBP-3[147,149], MSLN[148,154], C5[152], MMP-7[155-157], cathepsin-D[156], MMP-12[157], OPG[160], Kisspeptin[165], Galectin[171], MUC16[48,182], MUC5AC[37,182], PAM4[187], HSP27[190,191], CAM17.1[192,193], Fuc-Hpt[194], SAA[196], APN/CD13[200], M2-PK[203,204], APOA2[206-208], APOC1[209], APOC2[210], APOE[211-212], ITIH[213], APOA1[213], APOL1[213]
Growth factors	TGF-B[215], VEGF[217], FGF-10/KGF-2[138], PDGF[220], TSGF[221]
Cytokines and chemokines	IP-10[220], IL-6[220,230-232], MIC-1/GDF15[227,228], IL-11[229], YKL-40[232,233], IL-8[230,234,235,237,241], IL-10[214], IL-1β[214], OSM[138], TNF-α[240-244], M-CSF[214], CXCL11[138], SCF[138,247-248], Eotaxin[250], HGF[250], MCP-1[250], CXCL10[250]
Adhesion molecules	CEACAM1[253,254], ICAM-1[160,262-263]

CEA: Carcinoembryonic antigen; TTF: Thyroid transcription factor; sTRA: Sialylated tumor-related antigen; IL: Interleukin.

Citation: O'Neill RS, Stoita A. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket? World J Gastroenterol 2021; 27(26): 4045-4087
URL: https://www.wjgnet.com/1007-9327/full/v27/i26/4045.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i26.4045